Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Traws Pharma (TRAW) Restructuring Costs (2024 - 2025)

Historic Restructuring Costs for Traws Pharma (TRAW) over the last 2 years, with Q3 2025 value amounting to $499000.0.

  • Traws Pharma's Restructuring Costs fell 4866.26% to $499000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year change of. This contributed to the annual value of $3.3 million for FY2024, which is 1003.27% down from last year.
  • As of Q3 2025, Traws Pharma's Restructuring Costs stood at $499000.0, which was down 4866.26% from $545000.0 recorded in Q2 2025.
  • Over the past 5 years, Traws Pharma's Restructuring Costs peaked at $2.6 million during Q1 2024, and registered a low of $499000.0 during Q3 2025.